Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Colleen A. Lawton MD

Colleen A. Lawton MD profile photo picture

Emeritus Professor

Institution: Medical College of Wisconsin
Department: Radiation Oncology

View Curriculum Vitae

Publications (184)

  • Optimal Duration of Androgen Deprivation Therapy With Definitive Radiotherapy for Localized Prostate Cancer: A Meta-Analysis. (Zaorsky NG, Sun Y, Nabid A, Zapatero A, Bolla M, Joseph D, Maingon P, Guerrero A, Gonzalez AA, San-Segundo CG, Cabeza Rodríguez MÁ, Sole JM, Olivé AP, Steigler A, Souhami L, Carrier N, Armstrong JG, Gillham C, Pisansky TM, Schipper M, Sandler HM, Efstathiou JA, Lawton C, de Reijke TM, Attard G, Roy S, Morgan SC, Malone S, Hall WA, Nguyen PL, Shoag JE, Vince RA Jr, Calaway A, Garcia JA, Barata PC, Mendiratta P, Brown JR, Valle L, Rettig M, Dess RT, Jackson WC, Martin T, Jia AY, Steinberg M, Romero T, Kishan AU, Spratt DE) JAMA Oncol 2026 Jan 01;12(1):58-65 PMID: 41264309 PMCID: PMC12635924 SCOPUS ID: 2-s2.0-105023283707 11/20/2025       4 Citations
  • Assessing Quality and Adherence to PI-RADSv2.1 Minimum Technical Standards of Prostate MRI in NRG-GU005. (Alley S, Tonneau M, Olivié D, Tempany-Afdhal CM, Choyke PL, Turkbey IB, van der Heide UA, Ellis RJ, Kadoury S, Boike TP, Pennington JD, Frazier A, Lawton CAF, Leong N, Mihai AM, Morgan SC, Solanki AA, Michalski JM, Feng FY, Sandler HM, Menard C) J Magn Reson Imaging 2026 Feb;63(2):464-474 PMID: 41063518 PMCID: PMC12811001 SCOPUS ID: 2-s2.0-105018500681 10/09/2025    
  • Long-Term Results of NRG/RTOG 9601, a Randomized Trial of Radiation With or Without Antiandrogens in Patients Receiving Salvage Prostate Bed Radiation Therapy Postprostatectomy. (Lukka HR, Pugh SL, Shipley WU, Major PP, Sartor O, Dayes IS, Bahary JP, Efstathiou JA, Pisansky TM, Zeitzer KL, Lawton CAF, Dess RT, Camarata AS, Balogh AG, Souhami L, Rosenthal SA, Pennington JD, Seiferheld WF, Feng FY, Sandler HM) Int J Radiat Oncol Biol Phys 2025 Nov 15;123(4):990-999 PMID: 40752653 PMCID: PMC12875213 SCOPUS ID: 2-s2.0-105015978622 08/03/2025       4 Citations
  • Assessing the impact of a pre-processing pipeline on a tumor localization model in prostate MRI within a large multi-institutional dataset (NRGGU005) (Alley S, Tonneau M, Olivié D, Tempany-Afdhal CM, Choyke PL, Turkbey IB, van der Heide UA, Ellis RJ, Boike TP, Pennington JD, Frazier A, Lawton CAF, Leong N, Mihai AM, Morgan SC, Solanki AA, Michalski JM, Feng FY, Sandler H, Menard C, Kadoury S) Progress in Biomedical Optics and Imaging Proceedings of SPIE 2025;13410 SCOPUS ID: 2-s2.0-105004556500 01/01/2025    
  • Biopsy-based Basal-luminal Subtyping Classifier in High-risk Prostate Cancer: A Combined Analysis of the NRG Oncology/RTOG 9202, 9413, and 9902 Phase 3 Trials. (Patel KR, Nguyen PL, Proudfoot JA, Liu Y, Pra AD, Spratt DE, Pollack A, Sandler HM, Efstathiou JA, Lawton C, Simko JP, Rosenthal SA, Zeitzer KL, Mendez LC, Hartford AC, Hall WA, Desai AB, Pugh SL, Davicioni E, Tran PT, Feng FY) Eur Urol Oncol 2026 Apr;9(2):413-421 PMID: 39542826 PMCID: PMC12069648 SCOPUS ID: 2-s2.0-105037879155 11/15/2024       2 Citations
  • Changes in Daily Apparent Diffusion Coefficient on Fully Quantitative Magnetic Resonance Imaging Correlate With Established Genomic Pathways of Radiation Sensitivity and Reveal Novel Biologic Associations. (Hall WA, Mathison AJ, DeVoe E, Tschannen M, Wendt-Andrae J, Straza M, Awan M, Puckett LL, Lawton CAF, Schultz C, Urrutia R, Kerns S, Torres-Roca JF, Li XA, Erickson B, Nevalainen MT, Zimmermann MT, Paulson E) Int J Radiat Oncol Biol Phys 2024 Oct 01;120(2):570-578 PMID: 38819340 SCOPUS ID: 2-s2.0-85194948255 05/31/2024       1 Citation
  • Noninferiority of Hypofractionated vs Conventional Postprostatectomy Radiotherapy for Genitourinary and Gastrointestinal Symptoms: The NRG-GU003 Phase 3 Randomized Clinical Trial. (Buyyounouski MK, Pugh SL, Chen RC, Mann MJ, Kudchadker RJ, Konski AA, Mian OY, Michalski JM, Vigneault E, Valicenti RK, Barkati M, Lawton CAF, Potters L, Monitto DC, Kittel JA, Schroeder TM, Hannan R, Duncan CE, Rodgers JP, Feng F, Sandler HM) JAMA Oncol 2024 May 01;10(5):584-591 PMID: 38483412 PMCID: PMC10941019 SCOPUS ID: 2-s2.0-85187989092 03/14/2024       37 Citations
  • Long-term results of radiation with or without anti-androgens (AAT) in patients receiving salvage prostate bed radiation therapy (sRT) post prostatectomy. (Lukka H, Pugh SL, Shipley WU, Major P, Sartor AO, Dayes IS, Bahary JP, Efstathiou JA, Pisansky TM, Zeitzer KL, Lawton CA, Dess RT, Camarata AS, Balogh AG, Souhami L, Rosenthal SA, Seiferheld W, Feng FY, Sandler HM) Journal of Clinical Oncology 2024;42(4):320-320 SCOPUS ID: 2-s2.0-105024495105 01/01/2024    
  • Can I Leave? Perspectives on Parental Leave and Parenthood in Medical Training Among Program Directors and Trainees in Oncologic Specialties. (Beltrán Ponce S, Jagsi R, Florez N, Thomas CR Jr, Banerjee A, Jasti S, Bailey MM, Lawton CAF, Johnstone C, Clarke CN, Bedi M, Jovanovic M, Saeed H) J Womens Health (Larchmt) 2024 Feb;33(2):218-227 PMID: 38011014 SCOPUS ID: 2-s2.0-85179389889 11/27/2023       3 Citations
  • Patient-Specific Deep Learning Auto-Segmentation for MR-Guided Adaptive Radiotherapy of Prostate Cancer. (Amjad A, Chen X, Hall WA, Lawton CAF, Li A, Paulson ES) Int J Radiat Oncol Biol Phys 2023 Oct 01;117(2S):e638-e639 PMID: 37785902 10/03/2023    
  • Quality of Life in Prostate Cancer Patients Undergoing Daily Adaptive Versus Non-Adaptive Radiation Therapy Utilizing A 1.5 Tesla MR-Linac. (Ponce SEB, Daamen LA, Van der Voort vanZyp J, Westerhoff JM, Pos FJ, Christodouleas JP, Choudhury A, van der Heide U, Lawton CAF, Straza MW Jr, Bedi M, Paulson ES, Nasief HG, Li A, Verkooijen H, Tree A, Hall WA) Int J Radiat Oncol Biol Phys 2023 Oct 01;117(2S):S114-S115 PMID: 37784299 10/03/2023    
  • Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate. (Roy S, Romero T, Michalski JM, Feng FY, Efstathiou JA, Lawton CAF, Bolla M, Maingon P, de Reijke T, Joseph D, Ong WL, Sydes MR, Dearnaley DP, Tree AC, Carrier N, Nabid A, Souhami L, Incrocci L, Heemsbergen WD, Pos FJ, Zapatero A, Guerrero A, Alvarez A, San-Segundo CG, Maldonado X, Reiter RE, Rettig MB, Nickols NG, Steinberg ML, Valle LF, Ma TM, Farrell MJ, Neilsen BK, Juarez JE, Deng J, Vangala S, Avril N, Jia AY, Zaorsky NG, Sun Y, Spratt D, Kishan AU, Meta-Analysis of Randomized Trials in Cancer of the Prostate (MARCAP) Consortium Investigators) J Clin Oncol 2023 Nov 10;41(32):5005-5014 PMID: 37639648 PMCID: PMC10642893 SCOPUS ID: 2-s2.0-85173494659 08/28/2023       22 Citations
  • Development of Prostate Bed Delineation Consensus Guidelines for Magnetic Resonance Image-Guided Radiotherapy and Assessment of Its Effect on Interobserver Variability. (Sritharan K, Akhiat H, Cahill D, Choi S, Choudhury A, Chung P, Diaz J, Dysager L, Hall W, Huddart R, Kerkmeijer LGW, Lawton C, Mohajer J, Murray J, Nyborg CJ, Pos FJ, Rigo M, Schytte T, Sidhom M, Sohaib A, Tan A, van der Voort van Zyp J, Vesprini D, Zelefsky MJ, Tree AC) Int J Radiat Oncol Biol Phys 2024 Feb 01;118(2):378-389 PMID: 37633499 SCOPUS ID: 2-s2.0-85181813907 08/27/2023       5 Citations
  • Evolution in the Presence and Evidence Category of Radiation Therapy Treatment Recommendations in the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. (Conger RL, Mora J, Straza MW, Erickson BA, Lawton CAF, Schultz CJ, Currey A, Bedi M, Siker ML, Hall WA) Adv Radiat Oncol 2023;8(4):101206 PMID: 37152489 PMCID: PMC10157111 SCOPUS ID: 2-s2.0-85153041702 05/08/2023       3 Citations
  • Five-Year Patient-Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer. (Lukka HR, Deshmukh S, Bruner DW, Bahary JP, Lawton CAF, Efstathiou JA, Kudchadker RJ, Ponsky LE, Seaward SA, Dayes IS, Gopaul DD, Michalski JM, Delouya G, Kaplan ID, Horwitz EM, Roach M 3rd, Feng FY, Pugh SL, Sandler HM, Kachnic LA) Int J Radiat Oncol Biol Phys 2023 Jul 15;116(4):770-778 PMID: 36592721 PMCID: PMC10619484 SCOPUS ID: 2-s2.0-85149629320 01/03/2023       10 Citations
  • Confirming and Refining Our Existing Postoperative Treatment Strategies Through the Use of Novel Prostate-Specific Positron Emission Tomography (PET) Imaging. (Hall WA, Lawton CAF) Int J Radiat Oncol Biol Phys 2023 Jan 01;115(1):118-119 PMID: 36526378 SCOPUS ID: 2-s2.0-85143877126 12/17/2022    
  • Consensus Quality Measures and Dose Constraints for Prostate Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Expert Panel. (Solanki AA, Puckett LL, Kujundzic K, Katsoulakis E, Park J, Kapoor R, Hagan M, Kelly M, Palta J, Ballas LK, DeMarco J, Hoffman KE, Lawton CAF, Michalski J, Potters L, Zelefsky M, Kudner R, Dawes S, Wilson E, Sandler H) Pract Radiat Oncol 2023;13(2):e149-e165 PMID: 36522277 SCOPUS ID: 2-s2.0-85148380070 12/16/2022       9 Citations
  • Adaptive magnetic resonance image guided radiation for intact localized prostate cancer how to optimally test a rapidly emerging technology. (Hall WA, Kishan AU, Hall E, Nagar H, Vesprini D, Paulson E, Van der Heide UA, Lawton CAF, Kerkmeijer LGW, Tree AC) Front Oncol 2022;12:962897 PMID: 36132128 PMCID: PMC9484536 SCOPUS ID: 2-s2.0-85138290454 09/23/2022       3 Citations
  • Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Quality Measures Initiative. (Park J, Puckett LL, Katsoulakis E, Venkatesulu BP, Kujundzic K, Solanki AA, Movsas B, Simone CB 2nd, Sandler H, Lawton CA, Das P, Wo JY, Buchholz TA, Fisher CM, Harrison LB, Sher DJ, Kapoor R, Chapman CH, Dawes S, Kudner R, Wilson E, Hagan M, Palta J, Kelly MD) Pract Radiat Oncol 2022;12(6):468-474 PMID: 35690354 SCOPUS ID: 2-s2.0-85136277154 06/12/2022       7 Citations
  • The Influence of the Pretreatment Immune State on Response to Radiation Therapy in High-Risk Prostate Cancer: A Validation Study From NRG/RTOG 0521. (Hall WA, Karrison TG, Rosenthal SA, Amin MB, Gomella LG, Purdy JA, Sartor AO, Michalski JM, Garzotto MG, Bergom C, Jani AB, Lawton CAF, Simko JP, Moore JK, Gore EM, Lee WR, Nguyen PL, Danielson BL, Sandler HM, Feng FY) Int J Radiat Oncol Biol Phys 2022 Oct 01;114(2):266-274 PMID: 35675855 PMCID: PMC9444930 SCOPUS ID: 2-s2.0-85136601546 06/09/2022       4 Citations
  • ACR-ABS-ASTRO Practice Parameter for Transperineal Permanent Brachytherapy of Prostate Cancer. (Bittner NHJ, Cox BW, Davis B, King M, Lawton CAF, Merrick GS, Orio P, Ouhib Z, Rossi P, Showalter T, Small W Jr, Schechter NR) Am J Clin Oncol 2022 Jun 01;45(6):249-257 PMID: 35588224 SCOPUS ID: 2-s2.0-85130375609 05/20/2022       5 Citations
  • Ethics-Centered Guidelines for Social Media Use by Oncology Professionals: A Call to Action. (Shukla UC, Jimenez RB, Jagsi R, Rosenberg AR, Marron JM, Carfang LJ, Lawton CA, Dizon DS, Katz MS) JCO Oncol Pract 2022 Aug;18(8):537-540 PMID: 35507884 SCOPUS ID: 2-s2.0-85131157233 05/05/2022       3 Citations
  • General and custom deep learning autosegmentation models for organs in head and neck, abdomen, and male pelvis. (Amjad A, Xu J, Thill D, Lawton C, Hall W, Awan MJ, Shukla M, Erickson BA, Li XA) Med Phys 2022 Mar;49(3):1686-1700 PMID: 35094390 PMCID: PMC8917093 SCOPUS ID: 2-s2.0-85124464974 01/31/2022       35 Citations
  • Use of a DVH overlay technique for quality assurance of deformable image registration-based dose accumulation. (Kainz K, Garcia Alvarez J, Zhong H, Lim S, Ahunbay E, Tai A, Erickson B, Lawton C, Li XA) Med Phys 2022 Jan;49(1):611-623 PMID: 34826153 SCOPUS ID: 2-s2.0-85120889771 11/27/2021       15 Citations
  • The Model of an ASTRO Servant Leader. (DeWeese TL, Beyer D, Gunderson LL, Haffty BG, Harari PM, Lawton CA, Minsky BD, Steinberg ML) Int J Radiat Oncol Biol Phys 2021 Dec 01;111(5):1120-1121 PMID: 34793736 SCOPUS ID: 2-s2.0-85118654849 11/19/2021    
  • Characterization of Underrepresented Populations in Modern Era Clinical Trials Involving Radiation Therapy. (Bero EH, Rein LE, Banerjee A, Straza MW, Lawton CAF, Schultz CJ, Erickson BA, Siker ML, Hall WA) Pract Radiat Oncol 2021;11(6):453-459 PMID: 34742459 SCOPUS ID: 2-s2.0-85118502646 11/08/2021       8 Citations
  • Time management: Improving the timing of post-prostatectomy radiotherapy, clinical trials, and knowledge translation. (Yun Ooi K, Pereira I, Nagar H, Simcock R, Katz MS, Parker CC, Lawton C, Saeed H) Clin Transl Radiat Oncol 2021 Nov;31:21-27 PMID: 34522795 PMCID: PMC8424081 SCOPUS ID: 2-s2.0-85123121616 09/16/2021    
  • In Reply to Onal et al. (Hall WA, Lawton CAF, coauthors) Int J Radiat Oncol Biol Phys 2021 Jun 01;110(2):620-621 PMID: 33989589 SCOPUS ID: 2-s2.0-85105339930 05/15/2021       1 Citation
  • Reply to S. Sundar et al and S. Höcht et al. (Spratt DE, Malone S, Roy S, Sun Y, Lawton C) J Clin Oncol 2021 Jul 10;39(20):2316-2317 PMID: 33914593 SCOPUS ID: 2-s2.0-85112119667 04/30/2021    
  • Long-Term Outcomes of Dose-Escalated Pelvic Lymph Node Intensity-Modulated Radiation Therapy (IMRT) With a Simultaneous Hypofractionated Boost to the Prostate for Very High-Risk Adenocarcinoma of the Prostate: A Prospective Phase II Clinical Trial. (Hall WA, Bedi M, Kilari D, Bylow KA, Burfeind J, Johnstone C, Siker M, Currey A, See WA, Nelson A, Johnson S, Straza M, Lawton CAF) Pract Radiat Oncol 2021;11(6):527-533 PMID: 33848618 PMCID: PMC8638529 SCOPUS ID: 2-s2.0-85107984420 04/14/2021       6 Citations
  • Clinical Implementation and Initial Experience of Real-Time Motion Tracking With Jaws and Multileaf Collimator During Helical Tomotherapy Delivery. (Chen GP, Tai A, Puckett L, Gore E, Lim S, Keiper T, Johnstone C, Shukla M, Lawton C, Li XA) Pract Radiat Oncol 2021;11(5):e486-e495 PMID: 33578002 SCOPUS ID: 2-s2.0-85102461455 02/13/2021       33 Citations
  • Considering benefit and risk before routinely recommending SpaceOAR. (Hall WA, Tree AC, Dearnaley D, Parker CC, Prasad V, Roach M 3rd, Lawton CAF) Lancet Oncol 2021 Jan;22(1):11-13 PMID: 33387489 PMCID: PMC8882263 SCOPUS ID: 2-s2.0-85098657879 01/03/2021       42 Citations
  • Prostate Radiotherapy With Adjuvant Androgen Deprivation Therapy (ADT) Improves Metastasis-Free Survival Compared to Neoadjuvant ADT: An Individual Patient Meta-Analysis. (Spratt DE, Malone S, Roy S, Grimes S, Eapen L, Morgan SC, Malone J, Craig J, Dess RT, Jackson WC, Hartman HE, Kishan AU, Mehra R, Kaffenberger S, Morgan TM, Reichert ZR, Alumkal JJ, Michalski J, Lee WR, Pisansky TM, Feng FY, Shipley W, Sandler HM, Schipper MJ, Roach M 3rd, Sun Y, Lawton CAF) J Clin Oncol 2021 Jan 10;39(2):136-144 PMID: 33275486 PMCID: PMC8189640 SCOPUS ID: 2-s2.0-85099586804 12/05/2020       70 Citations
  • Development and Validation of a Genomic Tool to Predict Seminal Vesicle Invasion in Adenocarcinoma of the Prostate. (Hall WA, Fishbane N, Liu Y, Xu MJ, Davicioni E, Mahal BA, Den RB, Dess RT, Jackson WC, Wong AC, Schaeffer EM, Karnes RJ, Carroll PR, Cooperberg MR, Bismar TA, Kim HL, Klein EA, Davis JW, Ross AE, Tosoian JJ, Morgan TM, Mehra R, Salami SS, Nguyen PL, Lawton CAF, Spratt DE, Feng F) JCO Precis Oncol 2020 Nov;4:1228-1238 PMID: 35050780 SCOPUS ID: 2-s2.0-85095822574 11/01/2020       4 Citations
  • Pathways for Recruiting and Retaining Women and Underrepresented Minority Clinicians and Physician Scientists Into the Radiation Oncology Workforce: A Summary of the 2019 ASTRO/NCI Diversity Symposium Session at the ASTRO Annual Meeting (Suneja G, Mattes MD, Mailhot Vega RB, Escorcia FE, Lawton C, Greenberger J, Kesarwala AH, Spektor A, Vikram B, Deville C, Siker M) Advances in Radiation Oncology 1 September 2020;5(5):798-803 SCOPUS ID: 2-s2.0-85087028121 09/01/2020       13 Citations
  • NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate Cancer. (Hall WA, Paulson E, Davis BJ, Spratt DE, Morgan TM, Dearnaley D, Tree AC, Efstathiou JA, Harisinghani M, Jani AB, Buyyounouski MK, Pisansky TM, Tran PT, Karnes RJ, Chen RC, Cury FL, Michalski JM, Rosenthal SA, Koontz BF, Wong AC, Nguyen PL, Hope TA, Feng F, Sandler HM, Lawton CAF) Int J Radiat Oncol Biol Phys 2021 Jan 01;109(1):174-185 PMID: 32861817 PMCID: PMC7736505 SCOPUS ID: 2-s2.0-85092542250 08/31/2020       133 Citations
  • First, Do No Fistulization. (Lawton CAF) Int J Radiat Oncol Biol Phys 2020 Aug 01;107(5):866 PMID: 32698976 SCOPUS ID: 2-s2.0-85087773302 07/24/2020    
  • To Radiate or Not to Radiate-The Challenges of Pelvic Reirradiation. (Kamran SC, Zelefsky M, Nguyen PL, Lawton CAF) Semin Radiat Oncol 2020 Jul;30(3):238-241 PMID: 32503789 SCOPUS ID: 2-s2.0-85081976120 06/07/2020       7 Citations
  • A Prospective Multi-Institutional Phase I/II Trial of Step-Wise Dose-per-Fraction Escalation in Low and Intermediate Risk Prostate Cancer. (Ritter MA, Kupelian PA, Petereit DG, Lawton CA, Anger N, Geye H, Chappell RJ, Forman JD) Pract Radiat Oncol 2020;10(5):345-353 PMID: 32169590 PMCID: PMC7483248 SCOPUS ID: 2-s2.0-85083281084 03/15/2020       5 Citations
  • VA-Radiation Oncology Quality Surveillance Program. (Hagan M, Kapoor R, Michalski J, Sandler H, Movsas B, Chetty I, Lally B, Rengan R, Robinson C, Rimner A, Simone C, Timmerman R, Zelefsky M, DeMarco J, Hamstra D, Lawton C, Potters L, Valicenti R, Mutic S, Bosch W, Abraham C, Caruthers D, Brame R, Palta JR, Sleeman W, Nalluri J) Int J Radiat Oncol Biol Phys 2020 Mar 01;106(3):639-647 PMID: 31983560 SCOPUS ID: 2-s2.0-85078096238 01/28/2020       18 Citations
  • Prostate Cancer (Michalski JM, Pisansky TM, Lawton CA, Potters L) Gunderson and Tepper S Clinical Radiation Oncology 1 January 2020:1054-1114.e22 SCOPUS ID: 2-s2.0-105032932497 01/01/2020       1 Citation
  • Indications of Online Adaptive Replanning Based On Organ Deformation. (Lim SN, Ahunbay EE, Nasief H, Zheng C, Lawton C, Li XA) Pract Radiat Oncol 2020;10(2):e95-e102 PMID: 31446149 SCOPUS ID: 2-s2.0-85073000078 08/26/2019       11 Citations
  • Digital Rectal Examination Remains a Key Prognostic Tool for Prostate Cancer: A National Cancer Database Review. (Borkenhagen JF, Eastwood D, Kilari D, See WA, Van Wickle JD, Lawton CA, Hall WA) J Natl Compr Canc Netw 2019 Jul 01;17(7):829-837 PMID: 31319388 SCOPUS ID: 2-s2.0-85070084884 07/19/2019       15 Citations
  • Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO and AUA Evidence-Based Guideline. (Morgan SC, Hoffman K, Loblaw DA, Buyyounouski MK, Patton C, Barocas D, Bentzen S, Chang M, Efstathiou J, Greany P, Halvorsen P, Koontz BF, Lawton C, Leyrer CM, Lin D, Ray M, Sandler H) J Urol 2019 Mar;201(3):528-534 PMID: 30759696 SCOPUS ID: 2-s2.0-85061616197 02/15/2019       80 Citations
  • Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO, and AUA Evidence-Based Guideline. (Morgan SC, Hoffman K, Loblaw DA, Buyyounouski MK, Patton C, Barocas D, Bentzen S, Chang M, Efstathiou J, Greany P, Halvorsen P, Koontz BF, Lawton C, Leyrer CM, Lin D, Ray M, Sandler H) Pract Radiat Oncol 2018;8(6):354-360 PMID: 30322661 SCOPUS ID: 2-s2.0-85053825422 10/17/2018       206 Citations
  • Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial. (Roach M, Moughan J, Lawton CAF, Dicker AP, Zeitzer KL, Gore EM, Kwok Y, Seider MJ, Hsu IC, Hartford AC, Horwitz EM, Yamoah K, Jones CU, Michalski JM, Lee WR, Pisansky TM, Rabinovitch R, Rotman M, Pryzant RM, Kim HE, Thomas CR Jr, Shipley WU, Sandler HM) Lancet Oncol 2018 Nov;19(11):1504-1515 PMID: 30316827 PMCID: PMC6540797 SCOPUS ID: 2-s2.0-85057161270 10/15/2018       221 Citations
  • Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline. (Morgan SC, Hoffman K, Loblaw DA, Buyyounouski MK, Patton C, Barocas D, Bentzen S, Chang M, Efstathiou J, Greany P, Halvorsen P, Koontz BF, Lawton C, Leyrer CM, Lin D, Ray M, Sandler H) J Clin Oncol 2018 Oct 11;36(34):JCO1801097 PMID: 30307776 PMCID: PMC6269129 SCOPUS ID: 2-s2.0-85057552312 10/12/2018       154 Citations
  • Risk factors for late bowel and bladder toxicities in NRG Oncology prostate cancer trials of high-risk patients: A meta-analysis of physician-rated toxicities. (Xiao C, Moughan J, Movsas B, Konski AA, Hanks GE, Cox JD, Roach M 3rd, Zeitzer KL, Lawton CA, Peters CA, Rosenthal SA, Hsu IJ, Horwitz EM, Mishra MV, Michalski JM, Parliament MB, D'Souza DP, Pugh SL, Bruner DW) Adv Radiat Oncol 2018;3(3):405-411 PMID: 30202809 PMCID: PMC6128023 SCOPUS ID: 2-s2.0-85048093122 09/12/2018       3 Citations
  • Patient Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer. (Lukka HR, Pugh SL, Bruner DW, Bahary JP, Lawton CAF, Efstathiou JA, Kudchadker RJ, Ponsky LE, Seaward SA, Dayes IS, Gopaul DD, Michalski JM, Delouya G, Kaplan ID, Horwitz EM, Roach M 3rd, Pinover WH, Beyer DC, Amanie JO, Sandler HM, Kachnic LA) Int J Radiat Oncol Biol Phys 2018 Oct 01;102(2):287-295 PMID: 29913254 PMCID: PMC6248906 SCOPUS ID: 2-s2.0-85052200735 06/19/2018       69 Citations
  • Prostate Cancer: Improving the Flow of Research. (Lawton CAF) Radiology 2018 Apr;287(1):5-9 PMID: 29558314 SCOPUS ID: 2-s2.0-85044310391 03/21/2018       3 Citations
  • Magnetic Resonance Imaging-Guided Adaptive Radiation Therapy: A "Game Changer" for Prostate Treatment? (Pathmanathan AU, van As NJ, Kerkmeijer LGW, Christodouleas J, Lawton CAF, Vesprini D, van der Heide UA, Frank SJ, Nill S, Oelfke U, van Herk M, Li XA, Mittauer K, Ritter M, Choudhury A, Tree AC) Int J Radiat Oncol Biol Phys 2018 Feb 01;100(2):361-373 PMID: 29353654 SCOPUS ID: 2-s2.0-85041321822 01/23/2018       160 Citations
  • Improving CT quality with optimized image parameters for radiation treatment planning and delivery guidance (Chen GP, Noid G, Tai A, Liu F, Lawton C, Erickson B, Li XA) Physics and Imaging in Radiation Oncology October 2017;4:6-11 SCOPUS ID: 2-s2.0-85054543692 10/01/2017       32 Citations
  • Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-Term Update of NRG Oncology RTOG 9202. (Lawton CAF, Lin X, Hanks GE, Lepor H, Grignon DJ, Brereton HD, Bedi M, Rosenthal SA, Zeitzer KL, Venkatesan VM, Horwitz EM, Pisansky TM, Kim H, Parliament MB, Rabinovitch R, Roach M 3rd, Kwok Y, Dignam JJ, Sandler HM) Int J Radiat Oncol Biol Phys 2017 Jun 01;98(2):296-303 PMID: 28463149 PMCID: PMC5603177 SCOPUS ID: 2-s2.0-85018346032 05/04/2017       125 Citations
  • Adjuvant radiation therapy, androgen deprivation, and docetaxel for high-risk prostate cancer postprostatectomy: Results of NRG Oncology/RTOG study 0621. (Hurwitz MD, Harris J, Sartor O, Xiao Y, Shayegan B, Sperduto PW, Badiozamani KR, Lawton CAF, Horwitz EM, Michalski JM, Roof K, Beyer DC, Zhang Q, Sandler HM) Cancer 2017 Jul 01;123(13):2489-2496 PMID: 28323339 PMCID: PMC5474197 SCOPUS ID: 2-s2.0-85020917633 03/23/2017       17 Citations
  • Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer. (Shipley WU, Seiferheld W, Lukka HR, Major PP, Heney NM, Grignon DJ, Sartor O, Patel MP, Bahary JP, Zietman AL, Pisansky TM, Zeitzer KL, Lawton CA, Feng FY, Lovett RD, Balogh AG, Souhami L, Rosenthal SA, Kerlin KJ, Dignam JJ, Pugh SL, Sandler HM, NRG Oncology RTOG) N Engl J Med 2017 Feb 02;376(5):417-428 PMID: 28146658 PMCID: PMC5444881 SCOPUS ID: 2-s2.0-85011881295 02/02/2017       592 Citations
  • Effect of Long-Term Hormonal Therapy (vs Short-Term Hormonal Therapy): A Secondary Analysis of Intermediate-Risk Prostate Cancer Patients Treated on NRG Oncology RTOG 9202. (Mirhadi AJ, Zhang Q, Hanks GE, Lepor H, Grignon DJ, Peters CA, Rosenthal SA, Zeitzer K, Radwan JS, Lawton C, Parliament MB, Reznik RS, Sandler HM) Int J Radiat Oncol Biol Phys 2017 Mar 01;97(3):511-515 PMID: 28126300 PMCID: PMC5485922 SCOPUS ID: 2-s2.0-85009962502 01/28/2017       7 Citations
  • Biomarkers of Outcome in Patients With Localized Prostate Cancer Treated With Radiotherapy. (Hall WA, Lawton CA, Jani AB, Pollack A, Feng FY) Semin Radiat Oncol 2017 Jan;27(1):11-20 PMID: 27986207 SCOPUS ID: 2-s2.0-85006751493 12/18/2016       12 Citations
  • A Hybrid Adaptive Replanning Approach for Prostate Stereotactic Body Radiation Therapy (O. Ates E.E. Ahunbay C.A.F. Lawton A. Li) International Journal of Radiation Oncology, Biology, Physics POSTER VIEWING ABSTRACT| VOLUME 96, ISSUE 2, SUPPLEMENT , E668-E669, OCTOBER 01, 2016 10/01/2016    
  • MRI-guided prostate adaptive radiotherapy - A systematic review. (McPartlin AJ, Li XA, Kershaw LE, Heide U, Kerkmeijer L, Lawton C, Mahmood U, Pos F, van As N, van Herk M, Vesprini D, van der Voort van Zyp J, Tree A, Choudhury A, MR-Linac consortium) Radiother Oncol 2016 Jun;119(3):371-80 PMID: 27162159 SCOPUS ID: 2-s2.0-84965017473 05/11/2016       144 Citations
  • MRI-based IMRT planning for MR-linac: comparison between CT- and MRI-based plans for pancreatic and prostate cancers. (Prior P, Chen X, Botros M, Paulson ES, Lawton C, Erickson B, Li XA) Phys Med Biol 2016 May 21;61(10):3819-42 PMID: 27089554 SCOPUS ID: 2-s2.0-84969580052 04/19/2016       39 Citations
  • Quality of life outcomes from a dose-per-fraction escalation trial of hypofractionation in prostate cancer. (Brower JV, Forman JD, Kupelian PA, Petereit DG, Gondi V, Lawton CA, Anger N, Saha S, Chappell R, Ritter MA) Radiother Oncol 2016 Jan;118(1):99-104 PMID: 26755165 PMCID: PMC4764419 SCOPUS ID: 2-s2.0-84959507682 01/13/2016       11 Citations
  • Watchful Waiting-Active Surveillance in Low-Risk Prostate Cancer. (Haffty BG, Lawton CA, Sandler H) JAMA Oncol 2015 Aug;1(5):688-9 PMID: 26182350 SCOPUS ID: 2-s2.0-84983609892 07/17/2015       1 Citation
  • Prostate Cancer (Michalski JM, Pisansky TM, Lawton CAF, Potters L) Clinical Radiation Oncology 1 January 2015:1038-1095.e18 SCOPUS ID: 2-s2.0-85072327983 01/01/2015       3 Citations
  • Impact of biochemical failure classification on clinical outcome: a secondary analysis of Radiation Therapy Oncology Group 9202 and 9413. (Hamstra DA, Bae K, Hanks G, Hu C, Shipley WU, Pan CC, Roach M 3rd, Lawton CA, Sandler HM) Cancer 2015 Mar 15;121(6):844-52 PMID: 25410885 PMCID: PMC4657945 SCOPUS ID: 2-s2.0-84924182226 11/21/2014       2 Citations
  • Choosing wisely. (Lawton C) Pract Radiat Oncol 2014;4(6):356-7 PMID: 25407854 SCOPUS ID: 2-s2.0-84912144398 11/20/2014    
  • Combined online and offline adaptive radiation therapy: a dosimetric feasibility study. (Yang C, Liu F, Ahunbay E, Chang YW, Lawton C, Schultz C, Wang D, Firat S, Erickson B, Li XA) Pract Radiat Oncol 2014;4(1):e75-83 PMID: 24621436 SCOPUS ID: 2-s2.0-84890868988 03/14/2014       12 Citations
  • Assessment and management of interfractional variations in daily diagnostic-quality-CT guided prostate-bed irradiation after prostatectomy. (Liu F, Ahunbay E, Lawton C, Li XA) Med Phys 2014 Mar;41(3):031710 PMID: 24593714 SCOPUS ID: 2-s2.0-84896817518 03/07/2014       29 Citations
  • RTOG 0518: randomized phase III trial to evaluate zoledronic acid for prevention of osteoporosis and associated fractures in prostate cancer patients. (Kachnic LA, Pugh SL, Tai P, Smith M, Gore E, Shah AB, Martin AG, Kim HE, Nabid A, Lawton CA) Prostate Cancer Prostatic Dis 2013 Dec;16(4):382-6 PMID: 24080992 PMCID: PMC3830691 SCOPUS ID: 2-s2.0-84887613817 10/02/2013       33 Citations
  • Practice-based evidence to evidence-based practice: building the National Radiation Oncology Registry. (Efstathiou JA, Nassif DS, McNutt TR, Bogardus CB, Bosch W, Carlin J, Chen RC, Chou H, Eggert D, Fraass BA, Goldwein J, Hoffman KE, Hotz K, Hunt M, Kessler M, Lawton CA, Mayo C, Michalski JM, Mutic S, Potters L, Rose CM, Sandler HM, Sharp G, Tomé W, Tran PT, Wall T, Zietman AL, Gabriel PE, Bekelman JE) J Oncol Pract 2013 May;9(3):e90-5 PMID: 23942508 PMCID: PMC3651578 SCOPUS ID: 2-s2.0-84883261255 08/15/2013       29 Citations
  • Prostate-specific antigen response after short-term hormone therapy plus external-beam radiotherapy and outcome in patients treated on Radiation Therapy Oncology Group study 9413. (Cury FL, Hunt D, Roach M 3rd, Shipley W, Gore E, Hsu IC, Krisch RE, Seider MJ, Sandler H, Lawton C) Cancer 2013 Jun 01;119(11):1999-2004 PMID: 23504930 PMCID: PMC3663874 SCOPUS ID: 2-s2.0-84878016620 03/19/2013       17 Citations
  • National Radiation Oncology Registry: The pilot prostate cancer registry. (Nassif D, Chen RC, Hoffman KE, Kuban DA, Lawton CA, Michalski JM, Potters L, Rose CM, Sandler HM, Suh W, Wall T, Zietman AL, Bekelman JE) J Clin Oncol 2012 Dec;30(34_suppl):267 PMID: 28147066 12/01/2012    
  • SU-E-J-11: Characterization of Interfractioanal Anatomical Variations in Post-Operative Radiation Therapy for Prostate Bed. (Liu F, Ahunbay E, Christian R, Lawton C, Wang D, Li X) Med Phys 2012 Jun;39(6Part6):3654 PMID: 28517560 SCOPUS ID: 2-s2.0-85024816223 06/01/2012    
  • SU-E-T-579: Dosimetric Benefits of Online Adaptive Replanning for Post-Operative Radiation Therapy of Prostate Bed. (Liu F, Ahunbay E, Lawton C, Li X) Med Phys 2012 Jun;39(6Part19):3839 PMID: 28517059 SCOPUS ID: 2-s2.0-85024790010 06/01/2012    
  • Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas. (Gay HA, Barthold HJ, O'Meara E, Bosch WR, El Naqa I, Al-Lozi R, Rosenthal SA, Lawton C, Lee WR, Sandler H, Zietman A, Myerson R, Dawson LA, Willett C, Kachnic LA, Jhingran A, Portelance L, Ryu J, Small W Jr, Gaffney D, Viswanathan AN, Michalski JM) Int J Radiat Oncol Biol Phys 2012 Jul 01;83(3):e353-62 PMID: 22483697 PMCID: PMC3904368 SCOPUS ID: 2-s2.0-84861615341 04/10/2012       516 Citations
  • Kidney and adrenal gland (Lawton CA, Cohen EP, Moulder JE) Human Radiation Injury 28 March 2012:841-871 SCOPUS ID: 2-s2.0-85053584765 03/28/2012    
  • A research agenda for radiation oncology: results of the radiation oncology institute's comprehensive research needs assessment. (Jagsi R, Bekelman JE, Brawley OW, Deasy JO, Le QT, Michalski JM, Movsas B, Thomas CR Jr, Lawton CA, Lawrence TS, Hahn SM) Int J Radiat Oncol Biol Phys 2012 Oct 01;84(2):318-22 PMID: 22436790 SCOPUS ID: 2-s2.0-84865620496 03/23/2012       22 Citations
  • Impact of computed tomography image quality on image-guided radiation therapy based on soft tissue registration. (Morrow NV, Lawton CA, Qi XS, Li XA) Int J Radiat Oncol Biol Phys 2012 Apr 01;82(5):e733-8 PMID: 22349041 SCOPUS ID: 2-s2.0-84862816268 02/22/2012       46 Citations
  • Long-term results of an RTOG Phase II trial (00-19) of external-beam radiation therapy combined with permanent source brachytherapy for intermediate-risk clinically localized adenocarcinoma of the prostate. (Lawton CA, Yan Y, Lee WR, Gillin M, Firat S, Baikadi M, Crook J, Kuettel M, Morton G, Sandler H) Int J Radiat Oncol Biol Phys 2012 Apr 01;82(5):e795-801 PMID: 22330999 SCOPUS ID: 2-s2.0-84862776904 02/15/2012       55 Citations
  • Radiation Therapy Oncology Group (RTOG) 9413: Randomized trial comparing whole pelvic radiotherapy (WPRT) to prostate only (PORT) and neoadjuvant hormone therapy (NHT) to adjuvant hormone therapy (AHT). (Roach M, Yan Y, Lawton CA, Hsu IJ, Lustig RA, Jones CU, Rotman M, Zeitzer KL, Werner-Wasik M, Kim H, Thomas CR, Shipley WU, Sandler HM) J Clin Oncol 2012 Feb 10;30(5_suppl):96 PMID: 28143343 02/10/2012    
  • Developing a national radiation oncology registry: From acorns to oaks. (Palta JR, Efstathiou JA, Bekelman JE, Mutic S, Bogardus CR, McNutt TR, Gabriel PE, Lawton CA, Zietman AL, Rose CM) Pract Radiat Oncol 2012;2(1):10-7 PMID: 24674031 SCOPUS ID: 2-s2.0-84155165481 01/01/2012       35 Citations
  • Prostate Cancer (Michalski J, Pisansky TM, Lawton CA, Potters L, Kuban DA) Clinical Radiation Oncology Third Edition 2012:1037-1097 SCOPUS ID: 2-s2.0-84966785418 01/01/2012       2 Citations
  • Mitigation of late renal and pulmonary injury after hematopoietic stem cell transplantation. (Cohen EP, Bedi M, Irving AA, Jacobs E, Tomic R, Klein J, Lawton CA, Moulder JE) Int J Radiat Oncol Biol Phys 2012 May 01;83(1):292-6 PMID: 22104363 PMCID: PMC3299939 SCOPUS ID: 2-s2.0-84859878438 11/23/2011       64 Citations
  • Prostate Cancer (Michalski JM, Pisansky TM, Lawton CA, Potters L, Kuban DA) Clinical Radiation Oncology Third Edition October 27, 2011:e51.1-e51.85 SCOPUS ID: 2-s2.0-84967006860 10/27/2011    
  • Consolidating risk estimates for radiation-induced complications in individual patient: late rectal toxicity. (Prior P, Devisetty K, Tarima SS, Lawton CA, Semenenko VA) Int J Radiat Oncol Biol Phys 2012 May 01;83(1):53-63 PMID: 22024204 SCOPUS ID: 2-s2.0-84859825643 10/26/2011       2 Citations
  • Development of an online adaptive solution to account for inter- and intra-fractional variations. (Li XA, Liu F, Tai A, Ahunbay E, Chen G, Kelly T, Lawton C, Erickson B) Radiother Oncol 2011 Sep;100(3):370-4 PMID: 21924781 SCOPUS ID: 2-s2.0-80054084236 09/20/2011       48 Citations
  • Validation of an online replanning technique for prostate adaptive radiotherapy. (Peng C, Chen G, Ahunbay E, Wang D, Lawton C, Li XA) Phys Med Biol 2011 Jun 21;56(12):3659-68 PMID: 21610293 SCOPUS ID: 2-s2.0-79958090578 05/26/2011       21 Citations
  • Long-term results of a phase II trial of ultrasound-guided radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate (RTOG 98-05). (Lawton CA, Hunt D, Lee WR, Gomella L, Grignon D, Gillin M, Morton G, Pisansky TM, Sandler H) Int J Radiat Oncol Biol Phys 2011 Sep 01;81(1):1-7 PMID: 21470793 PMCID: PMC3132830 SCOPUS ID: 2-s2.0-79961128020 04/08/2011       34 Citations
  • Older age predicts decreased metastasis and prostate cancer-specific death for men treated with radiation therapy: meta-analysis of radiation therapy oncology group trials. (Hamstra DA, Bae K, Pilepich MV, Hanks GE, Grignon DJ, McGowan DG, Roach M, Lawton C, Lee RJ, Sandler H) Int J Radiat Oncol Biol Phys 2011 Dec 01;81(5):1293-301 PMID: 21458924 PMCID: PMC4675045 SCOPUS ID: 2-s2.0-80255140736 04/05/2011       43 Citations
  • TH‐C‐BRA‐04: Online Adaptive Radiotherapy for Prostate Cancer: Clinical Implementation and Initial Experience (li XA, Ahunbay E, Peng C, Chen G, Liu F, Lawton C) Medical Physics June 2011;38(6):3852-3853 SCOPUS ID: 2-s2.0-85024791459 01/01/2011    
  • SU‐E‐T‐647: Quality of Prostate IMRT Plans Generated Using Biological versus Dose‐Volume Constraints Medical Physics June 2011;38(6):3638 SCOPUS ID: 2-s2.0-85024825576 01/01/2011    
  • Prostate Cancer (Michalski J, Pisansky TM, Lawton CA, Potters L, Kuban DA) Clinical Radiation Oncology Third Edition 1 January 2011:1037-1097 SCOPUS ID: 2-s2.0-85167741698 01/01/2011       1 Citation
  • Evaluation of nuclear factor κB and chemokine receptor CXCR4 co-expression in patients with prostate cancer in the Radiation Therapy Oncology Group (RTOG) 8610. (Okera M, Bae K, Bernstein E, Cheng L, Lawton C, Wolkov H, Pollack A, Dicker A, Sandler H, Sweeney CJ) BJU Int 2011 Jul;108(2 Pt 2):E51-8 PMID: 21156016 PMCID: PMC3062644 SCOPUS ID: 2-s2.0-79960107662 12/16/2010       18 Citations
  • Characterizing interfraction variations and their dosimetric effects in prostate cancer radiotherapy. (Peng C, Ahunbay E, Chen G, Anderson S, Lawton C, Li XA) Int J Radiat Oncol Biol Phys 2011 Mar 01;79(3):909-14 PMID: 20732764 SCOPUS ID: 2-s2.0-79551468706 08/25/2010       70 Citations
  • Impact of ultrahigh baseline PSA levels on biochemical and clinical outcomes in two Radiation Therapy Oncology Group prostate clinical trials. (Rodrigues G, Bae K, Roach M, Lawton C, Donnelly B, Grignon D, Hanks G, Porter A, Lepor H, Sandler H) Int J Radiat Oncol Biol Phys 2011 Jun 01;80(2):445-52 PMID: 20615632 PMCID: PMC2952349 SCOPUS ID: 2-s2.0-79955578017 07/10/2010       14 Citations
  • To treat pelvic nodes or not? Greater testicular scatter does not explain the results of randomized trials. (Roach M 3rd, Lawton CA, Chen J) J Clin Oncol 2010 Sep 01;28(25):e450-2 PMID: 20567007 SCOPUS ID: 2-s2.0-77957561757 06/23/2010       5 Citations
  • Baseline serum testosterone in men treated with androgen deprivation therapy and radiotherapy for localized prostate cancer. (Roach M 3rd, Bae K, Lawton C, Donnelly BJ, Grignon D, Hanks GE, Porter A, Lepor H, Venketesan V, Sandler H) Int J Radiat Oncol Biol Phys 2010 Dec 01;78(5):1314-22 PMID: 20378270 PMCID: PMC2920356 SCOPUS ID: 2-s2.0-78549231887 04/10/2010       17 Citations
  • Online adaptive replanning method for prostate radiotherapy. (Ahunbay EE, Peng C, Holmes S, Godley A, Lawton C, Li XA) Int J Radiat Oncol Biol Phys 2010 Aug 01;77(5):1561-72 PMID: 20362401 SCOPUS ID: 2-s2.0-77955506120 04/07/2010       86 Citations
  • SU‐GG‐T‐29: Dosimetric Advantages of Online Adaptive Replanning for Radiotherapy of the Prostate and Seminal Vesicles (Holmes S, Peng C, Ahunbay E, Lawton C, Wang D, li X) Medical Physics June 2010;37(6):3190 SCOPUS ID: 2-s2.0-79958172646 01/01/2010       2 Citations
  • Follicular lymphoma transformation to dual translocated Burkitt-like lymphoma: improved disease control associated with radiation therapy. (Parker SM, Olteanu H, VanTuinen P, Lawton CA, Schultz CJ, Christians KK, Fenske TS) Int J Hematol 2009 Dec;90(5):616-622 PMID: 19937165 SCOPUS ID: 2-s2.0-73449127535 11/26/2009       11 Citations
  • Results of the Association of Directors of Radiation Oncology Programs (ADROP) survey of radiation oncology residency program directors. (Harris EE, Abdel-Wahab M, Spangler AE, Lawton CA, Amdur RJ) Int J Radiat Oncol Biol Phys 2009 Jun 01;74(2):327-37 PMID: 19427549 SCOPUS ID: 2-s2.0-65449164335 05/12/2009       13 Citations
  • Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer. (Michalski JM, Lawton C, El Naqa I, Ritter M, O'Meara E, Seider MJ, Lee WR, Rosenthal SA, Pisansky T, Catton C, Valicenti RK, Zietman AL, Bosch WR, Sandler H, Buyyounouski MK, Ménard C) Int J Radiat Oncol Biol Phys 2010 Feb 01;76(2):361-8 PMID: 19394158 PMCID: PMC2847420 SCOPUS ID: 2-s2.0-73649096560 04/28/2009       359 Citations
  • ACR appropriateness criteria on external beam radiation therapy treatment planning for clinically localized prostate cancer expert panel on radiation oncology--prostate. (Michalski JM, Roach M 3rd, Merrick G, Anscher MS, Beyer DC, Lawton CA, Lee WR, Pollack A, Rosenthal SA, Vijayakumar S, Carroll PR) Int J Radiat Oncol Biol Phys 2009 Jul 01;74(3):667-72 PMID: 19386445 SCOPUS ID: 2-s2.0-67049172698 04/24/2009       16 Citations
  • Hypofractionation for prostate cancer. (Ritter M, Forman J, Kupelian P, Lawton C, Petereit D) Cancer J 2009;15(1):1-6 PMID: 19197165 PMCID: PMC3039916 SCOPUS ID: 2-s2.0-61449210091 02/07/2009       67 Citations
  • A comparison of daily megavoltage CT and ultrasound image guided radiation therapy for prostate cancer. (Peng C, Kainz K, Lawton C, Li XA) Med Phys 2008 Dec;35(12):5619-28 PMID: 19175119 SCOPUS ID: 2-s2.0-56749165429 01/30/2009       25 Citations
  • SU‐FF‐J‐132: Calculation of Cumulative Dose for Daily CT‐Guided Prostate Irradiation Using Deformable Image Registration (Godley A, Ahunbay E, Lawton C, li X) Medical Physics June 2009;36(6):2507 SCOPUS ID: 2-s2.0-79958079799 01/01/2009       1 Citation
  • SU‐FF‐T‐79: Dosimetric QA Tests of An Online Replanning Technique for Prostate Adaptive Radiotherapy (Peng C, Ahunbay E, Chen G, Lawton C, li X) Medical Physics June 2009;36(6):2537 SCOPUS ID: 2-s2.0-85024820120 01/01/2009       1 Citation
  • Variation in the definition of clinical target volumes for pelvic nodal conformal radiation therapy for prostate cancer. (Lawton CA, Michalski J, El-Naqa I, Kuban D, Lee WR, Rosenthal SA, Zietman A, Sandler H, Shipley W, Ritter M, Valicenti R, Catton C, Roach M 3rd, Pisansky TM, Seider M) Int J Radiat Oncol Biol Phys 2009 Jun 01;74(2):377-82 PMID: 18947941 PMCID: PMC2905162 SCOPUS ID: 2-s2.0-67349210198 10/25/2008       62 Citations
  • RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer. (Lawton CA, Michalski J, El-Naqa I, Buyyounouski MK, Lee WR, Menard C, O'Meara E, Rosenthal SA, Ritter M, Seider M) Int J Radiat Oncol Biol Phys 2009 Jun 01;74(2):383-7 PMID: 18947938 PMCID: PMC2905150 SCOPUS ID: 2-s2.0-67349188234 10/25/2008       369 Citations
  • An on-line replanning scheme for interfractional variations. (Ahunbay EE, Peng C, Chen GP, Narayanan S, Yu C, Lawton C, Li XA) Med Phys 2008 Aug;35(8):3607-15 PMID: 18777921 SCOPUS ID: 2-s2.0-48349124822 09/10/2008       124 Citations
  • In Reply to Drs. Williams and Wiltshire Regarding Update of RTOG 94-13 (Lawton CA, Bae K) International Journal of Radiation Oncology Biology Physics 1 May 2008;71(1):315-316 SCOPUS ID: 2-s2.0-41749090501 05/01/2008    
  • In Response to Dr. Millar et al. (Lawton CA) International Journal of Radiation Oncology Biology Physics 1 May 2008;71(1):316 SCOPUS ID: 2-s2.0-41749089607 05/01/2008    
  • Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer. (Horwitz EM, Bae K, Hanks GE, Porter A, Grignon DJ, Brereton HD, Venkatesan V, Lawton CA, Rosenthal SA, Sandler HM, Shipley WU) J Clin Oncol 2008 May 20;26(15):2497-504 PMID: 18413638 SCOPUS ID: 2-s2.0-45149105820 04/17/2008       611 Citations
  • Does timing of androgen deprivation influence radiation-induced toxicity? A secondary analysis of radiation therapy oncology group protocol 9413. (Taussky D, Bae K, Bahary JP, Roach M 3rd, Lawton CA, Shipley WU, Sandler HM) Urology 2008 Nov;72(5):1125-9 PMID: 18314175 SCOPUS ID: 2-s2.0-54449083092 03/04/2008       12 Citations
  • Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: long-term results of RTOG 8610. (Roach M 3rd, Bae K, Speight J, Wolkov HB, Rubin P, Lee RJ, Lawton C, Valicenti R, Grignon D, Pilepich MV) J Clin Oncol 2008 Feb 01;26(4):585-91 PMID: 18172188 SCOPUS ID: 2-s2.0-39149085396 01/04/2008       581 Citations
  • WE‐E‐AUD C‐02: Impact of Image Quality On CT Guided Prostate Radiotherapy (Morrow N, Lawton C, li X) Medical Physics June 2008;35(6):2955 SCOPUS ID: 2-s2.0-79551472445 01/01/2008       2 Citations
  • Pelvic lymph node irradiation for prostate cancer: who, why, and when? (Wang D, Lawton C) Semin Radiat Oncol 2008 Jan;18(1):35-40 PMID: 18082586 SCOPUS ID: 2-s2.0-36849070850 12/18/2007       18 Citations
  • Designing equivalent treatment regimens for prostate radiotherapy based on equivalent uniform dose. (Li XA, Wang JZ, Stewart RD, Dibiase SJ, Wang D, Lawton CA) Br J Radiol 2008 Jan;81(961):59-68 PMID: 18039721 SCOPUS ID: 2-s2.0-38449113806 11/28/2007       10 Citations
  • Long-term treatment sequelae after external beam irradiation with or without hormonal manipulation for adenocarcinoma of the prostate: analysis of radiation therapy oncology group studies 85-31, 86-10, and 92-02. (Lawton CA, Bae K, Pilepich M, Hanks G, Shipley W) Int J Radiat Oncol Biol Phys 2008 Feb 01;70(2):437-41 PMID: 17881145 PMCID: PMC2917176 SCOPUS ID: 2-s2.0-38149087621 09/21/2007       71 Citations
  • Adjuvant androgen deprivation therapy augments cure and long-term cancer control in men with poor prognosis, nonmetastatic prostate cancer. (Fleshner N, Keane TE, Lawton CA, Mulders PF, Payne H, Taneja SS, Morris T) Prostate Cancer Prostatic Dis 2008;11(1):46-52 PMID: 17607304 SCOPUS ID: 2-s2.0-39149123530 07/04/2007       8 Citations
  • An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions. (Lawton CA, DeSilvio M, Roach M 3rd, Uhl V, Kirsch R, Seider M, Rotman M, Jones C, Asbell S, Valicenti R, Hahn S, Thomas CR Jr) Int J Radiat Oncol Biol Phys 2007 Nov 01;69(3):646-55 PMID: 17531401 PMCID: PMC2917177 SCOPUS ID: 2-s2.0-34548682063 05/29/2007       423 Citations
  • Late toxicity and biochemical recurrence after external-beam radiotherapy combined with permanent-source prostate brachytherapy: analysis of Radiation Therapy Oncology Group study 0019. (Lee WR, Bae K, Lawton C, Gillin M, Morton G, Firat S, Baikadi M, Kuettel M, Greven K, Sandler H) Cancer 2007 Apr 15;109(8):1506-12 PMID: 17340591 SCOPUS ID: 2-s2.0-34247128677 03/07/2007       60 Citations
  • Treatment Options in Prostate Cancer Once Primary Therapy Fails (Keane T, Gillatt D, Lawton C, Payne H, Tombal B) European Urology Supplements March 2007;6(3):344-353 SCOPUS ID: 2-s2.0-33846460440 03/01/2007       4 Citations
  • Localised and Locally Advanced Prostate Cancer: Who to Treat and How? (Gillatt D, Klotz L, Lawton C, Miller K, Payne H) European Urology Supplements March 2007;6(3):334-343 SCOPUS ID: 2-s2.0-33846454377 03/01/2007       1 Citation
  • SU‐FF‐J‐45: A Comparison of Daily Megavoltage CT and Ultrasound Imaging Guided Radiation Therapy for Prostate Cancer (Peng C, Kainz K, Lawton C, li X) Medical Physics June 2007;34(6):2378 SCOPUS ID: 2-s2.0-85024794577 01/01/2007    
  • A descriptive analysis of postimplant dosimetric parameters from Radiation Therapy Oncology Group P0019. (Lee WR, Bae K, Lawton CA, Gillin MT, Morton G, Firat S, Baikadi M, Kuettel M, Greven K, Sandler H) Brachytherapy 2006;5(4):239-43 PMID: 17118317 SCOPUS ID: 2-s2.0-33750996693 11/23/2006       18 Citations
  • Results of a phase II trial of transrectal ultrasound-guided permanent radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate (radiation therapy oncology group 98-05). (Lawton CA, DeSilvio M, Lee WR, Gomella L, Grignon D, Gillin M, Morton G, Pisansky T, Sandler H) Int J Radiat Oncol Biol Phys 2007 Jan 01;67(1):39-47 PMID: 17084551 SCOPUS ID: 2-s2.0-33845616733 11/07/2006       47 Citations
  • Whole-pelvis, "mini-pelvis," or prostate-only external beam radiotherapy after neoadjuvant and concurrent hormonal therapy in patients treated in the Radiation Therapy Oncology Group 9413 trial. (Roach M 3rd, DeSilvio M, Valicenti R, Grignon D, Asbell SO, Lawton C, Thomas CR Jr, Shipley WU) Int J Radiat Oncol Biol Phys 2006 Nov 01;66(3):647-53 PMID: 17011443 SCOPUS ID: 2-s2.0-33748937011 10/03/2006       174 Citations
  • Quality assurance methods for the first Radiation Therapy Oncology Group permanent prostate implant protocol. (Gillin MT, Dunning BF, Lawton CA, Foley WD, Byhardt RW, Morton G, Baikadi M, Pisansky TT, Michalski JM, Ibbott G, Lopez F, Radiation Therapy Oncology Group) Brachytherapy 2006;5(3):152-6 PMID: 16864066 SCOPUS ID: 2-s2.0-33746058970 07/26/2006       4 Citations
  • Influence of number of CAG repeats on local control in the RTOG 86-10 protocol. (Abdel-Wahab M, Berkey BA, Krishan A, O'Brien T, Hammond E, Roach M 3rd, Lawton C, Pilepich M, Markoe A, Pollack A) Am J Clin Oncol 2006 Feb;29(1):14-20 PMID: 16462497 SCOPUS ID: 2-s2.0-33644868152 02/08/2006       16 Citations
  • Early initiation of salvage hormone therapy influences survival in patients who failed initial radiation for locally advanced prostate cancer: A secondary analysis of RTOG protocol 86-10. (Shipley WU, Desilvio M, Pilepich MV, Roach M 3rd, Wolkov HB, Sause WT, Rubin P, Lawton CA) Int J Radiat Oncol Biol Phys 2006 Mar 15;64(4):1162-7 PMID: 16427211 SCOPUS ID: 2-s2.0-33644532216 01/24/2006       48 Citations
  • A phase II study of external beam radiotherapy combined with permanent source brachytherapy for intermediate-risk, clinically localized adenocarcinoma of the prostate: preliminary results of RTOG P-0019. (Lee WR, DeSilvio M, Lawton C, Gillin M, Morton G, Firat S, Baikadi M, Kuettel M, Greven K, Sandler H) Int J Radiat Oncol Biol Phys 2006 Mar 01;64(3):804-9 PMID: 16289906 SCOPUS ID: 2-s2.0-31844448946 11/18/2005       34 Citations
  • Health-related quality of life in men receiving prostate brachytherapy on RTOG 98-05. (Feigenberg SJ, Lee WR, Desilvio ML, Winter K, Pisansky TM, Bruner DW, Lawton C, Morton G, Baikadi M, Sandler H) Int J Radiat Oncol Biol Phys 2005 Jul 15;62(4):956-64 PMID: 15989995 SCOPUS ID: 2-s2.0-21244452660 07/02/2005       55 Citations
  • Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma--long-term results of phase III RTOG 85-31. (Pilepich MV, Winter K, Lawton CA, Krisch RE, Wolkov HB, Movsas B, Hug EB, Asbell SO, Grignon D) Int J Radiat Oncol Biol Phys 2005 Apr 01;61(5):1285-90 PMID: 15817329 SCOPUS ID: 2-s2.0-16344385883 04/09/2005       858 Citations
  • Dosimetric advantages of IMRT simultaneous integrated boost for high-risk prostate cancer. (Li XA, Wang JZ, Jursinic PA, Lawton CA, Wang D) Int J Radiat Oncol Biol Phys 2005 Mar 15;61(4):1251-7 PMID: 15752907 SCOPUS ID: 2-s2.0-14844309346 03/09/2005       62 Citations
  • Androgen suppression plus radiation versus radiation alone for patients with stage D1/pathologic node-positive adenocarcinoma of the prostate: updated results based on national prospective randomized trial Radiation Therapy Oncology Group 85-31. (Lawton CA, Winter K, Grignon D, Pilepich MV) J Clin Oncol 2005 Feb 01;23(4):800-7 PMID: 15681524 SCOPUS ID: 2-s2.0-14144256590 02/01/2005       161 Citations
  • Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma - Long-term results of phase III RTOG 85-31 (Pilepich MV, Winter K, Lawton CA, Krisch RE, Wolkov HB, Movsas B, Hug EB, Asbell SO, Grignon D, Carroll PR) Urologic Oncology Seminars and Original Investigations November/December 2005;23(6):462-463 SCOPUS ID: 2-s2.0-27844583379 01/01/2005       1 Citation
  • Ki-67 staining is a strong predictor of distant metastasis and mortality for men with prostate cancer treated with radiotherapy plus androgen deprivation: Radiation Therapy Oncology Group Trial 92-02. (Pollack A, DeSilvio M, Khor LY, Li R, Al-Saleem TI, Hammond ME, Venkatesan V, Lawton CA, Roach M 3rd, Shipley WU, Hanks GE, Sandler HM) J Clin Oncol 2004 Jun 01;22(11):2133-40 PMID: 15169799 SCOPUS ID: 2-s2.0-2942644682 06/01/2004       147 Citations
  • Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02. (Hanks GE, Pajak TF, Porter A, Grignon D, Brereton H, Venkatesan V, Horwitz EM, Lawton C, Rosenthal SA, Sandler HM, Shipley WU, Radiation Therapy Oncology Group) J Clin Oncol 2003 Nov 01;21(21):3972-8 PMID: 14581419 SCOPUS ID: 2-s2.0-0642311912 10/29/2003       686 Citations
  • Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413. (Roach M 3rd, DeSilvio M, Lawton C, Uhl V, Machtay M, Seider MJ, Rotman M, Jones C, Asbell SO, Valicenti RK, Han S, Thomas CR Jr, Shipley WS, Radiation Therapy Oncology Group 9413) J Clin Oncol 2003 May 15;21(10):1904-11 PMID: 12743142 SCOPUS ID: 2-s2.0-0037674063 05/14/2003       618 Citations
  • Hormones and radiation therapy in locally advanced adenocarcinoma of the prostate. (Lawton CA) Semin Radiat Oncol 2003 Apr;13(2):141-51 PMID: 12728443 SCOPUS ID: 2-s2.0-0038304594 05/03/2003       9 Citations
  • Prostate cancer DNA ploidy and response to salvage hormone therapy after radiotherapy with or without short-term total androgen blockade: an analysis of RTOG 8610. (Pollack A, Grignon DJ, Heydon KH, Hammond EH, Lawton CA, Mesic JB, Fu KK, Porter AT, Abrams RA, Shipley WU) J Clin Oncol 2003 Apr 01;21(7):1238-48 PMID: 12663710 SCOPUS ID: 2-s2.0-0037500178 03/29/2003       31 Citations
  • Effect of a short course of neoadjuvant hormonal therapy on the response to subsequent androgen suppression in prostate cancer patients with relapse after radiotherapy: a secondary analysis of the randomized protocol RTOG 86-10. (Shipley WU, Lu JD, Pilepich MV, Heydon K, Roach M, Wolkov HB, Sause WT, Rubin P, Lawton CA, Machtay M) Int J Radiat Oncol Biol Phys 2002 Dec 01;54(5):1302-10 PMID: 12459350 SCOPUS ID: 2-s2.0-0036890728 12/03/2002       61 Citations
  • Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion. (Keever-Taylor CA, Bredeson C, Loberiza FR, Casper JT, Lawton C, Rizzo D, Burns WH, Margolis DA, Vesole DH, Horowitz M, Zhang MJ, Juckett M, Drobyski WR) Biol Blood Marrow Transplant 2001;7(11):620-30 PMID: 11760150 SCOPUS ID: 2-s2.0-0034747266 01/05/2002       58 Citations
  • Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate. (Pilepich MV, Winter K, John MJ, Mesic JB, Sause W, Rubin P, Lawton C, Machtay M, Grignon D) Int J Radiat Oncol Biol Phys 2001 Aug 01;50(5):1243-52 PMID: 11483335 SCOPUS ID: 2-s2.0-0035424063 08/03/2001       763 Citations
  • Loss of renal function following bone marrow transplantation: an analysis of angiotensin converting enzyme D/I polymorphism and other clinical risk factors. (Juckett MB, Cohen EP, Keever-Taylor CA, Zheng Y, Lawton CA, Moulder JE, Klein J) Bone Marrow Transplant 2001 Feb;27(4):451-6 PMID: 11313676 SCOPUS ID: 2-s2.0-0035094980 04/21/2001       24 Citations
  • Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate. (Lawton CA, Winter K, Murray K, Machtay M, Mesic JB, Hanks GE, Coughlin CT, Pilepich MV) Int J Radiat Oncol Biol Phys 2001 Mar 15;49(4):937-46 PMID: 11240234 SCOPUS ID: 2-s2.0-0035869725 03/10/2001       374 Citations
  • Subset analysis of RTOG 85-31 and 86-10 indicates an advantage for long-term vs. short-term adjuvant hormones for patients with locally advanced nonmetastatic prostate cancer treated with radiation therapy. (Horwitz EM, Winter K, Hanks GE, Lawton CA, Russell AH, Machtay M) Int J Radiat Oncol Biol Phys 2001 Mar 15;49(4):947-56 PMID: 11240235 SCOPUS ID: 2-s2.0-0035869703 03/10/2001       103 Citations
  • Predicting long-term survival, and the need for hormonal therapy: a meta-analysis of RTOG prostate cancer trials. (Roach M 3RD, Lu J, Pilepich MV, Asbell SO, Mohiuddin M, Terry R, Grignon D, Lawton C, Shipley W, Cox J) Int J Radiat Oncol Biol Phys 2000 Jun 01;47(3):617-27 PMID: 10837944 SCOPUS ID: 2-s2.0-16744367679 06/06/2000       180 Citations
  • The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): a quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies. (Movsas B, Scott C, Sause W, Byhardt R, Komaki R, Cox J, Johnson D, Lawton C, Dar AR, Wasserman T, Roach M, Lee JS, Andras E) Int J Radiat Oncol Biol Phys 1999 Dec 01;45(5):1143-9 PMID: 10613306 SCOPUS ID: 2-s2.0-0032794019 12/29/1999       120 Citations
  • Prostatic carcinoma. (Lawton CA, Grignon D, Newhouse JH, Schellhammer PF, Kuban DA) Radiographics 1999;19(1):185-203 PMID: 9925399 SCOPUS ID: 2-s2.0-0032608421 01/30/1999       3 Citations
  • Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung. (Byhardt RW, Scott C, Sause WT, Emami B, Komaki R, Fisher B, Lee JS, Lawton C) Int J Radiat Oncol Biol Phys 1998 Oct 01;42(3):469-78 PMID: 9806503 SCOPUS ID: 2-s2.0-0031724258 11/07/1998       221 Citations
  • T cell-depleted allogeneic bone marrow transplantation for high-risk non-Hodgkin's lymphoma: clinical and molecular follow-up. (Juckett M, Rowlings P, Hessner M, Keever-Taylor C, Burns W, Camitta B, Casper J, Drobyski WR, Hanson G, Horowitz M, Lawton C, Margolis J, Peitryga D, Vesole D) Bone Marrow Transplant 1998 May;21(9):893-9 PMID: 9613781 SCOPUS ID: 2-s2.0-0031894170 06/05/1998       49 Citations
  • Long-term results of selective renal shielding in patients undergoing total body irradiation in preparation for bone marrow transplantation. (Lawton CA, Cohen EP, Murray KJ, Derus SW, Casper JT, Drobyski WR, Horowitz MM, Moulder JE) Bone Marrow Transplant 1997 Dec;20(12):1069-74 PMID: 9466280 SCOPUS ID: 2-s2.0-0031437525 02/18/1998       111 Citations
  • Adoptive immunotherapy for leukemia: donor lymphocytes transduced with the herpes simplex thymidine kinase gene for remission induction. HGTRI 0103. (Link CJ Jr, Burt RK, Traynor AE, Drobyski WR, Seregina T, Levy JP, Gordon L, Rosen ST, Burns WH, Camitta B, Casper J, Horowitz M, Juckett M, Lawton C, Margolis D, Pietryga D, Rowlings P, Taylor C, Furtado M, Stefka J, Gupta-Burt S, Kaiser H, Vesole DH) Hum Gene Ther 1998 Jan 01;9(1):115-34 PMID: 9458247 SCOPUS ID: 2-s2.0-0031975258 02/11/1998       37 Citations
  • Node-positive prostatic carcinoma. (Lawton C) Int J Radiat Oncol Biol Phys 1997 Oct 01;39(3):671-2 PMID: 9336148 SCOPUS ID: 2-s2.0-0030930060 10/23/1997       1 Citation
  • Androgen suppression plus radiation versus radiation alone for patients with D1 (pN+) adenocarcinoma of the prostate (results based on a national prospective randomized trial, RTOG 85-31). Radiation Therapy Oncology Group. (Lawton CA, Winter K, Byhardt R, Sause WT, Hanks GE, Russell AH, Rotman M, Porter A, McGowan DG, DelRowe JD, Pilepich MV) Int J Radiat Oncol Biol Phys 1997 Jul 15;38(5):931-9 PMID: 9276357 SCOPUS ID: 2-s2.0-0030798806 07/15/1997       74 Citations
  • Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31. (Pilepich MV, Caplan R, Byhardt RW, Lawton CA, Gallagher MJ, Mesic JB, Hanks GE, Coughlin CT, Porter A, Shipley WU, Grignon D) J Clin Oncol 1997 Mar;15(3):1013-21 PMID: 9060541 SCOPUS ID: 2-s2.0-0031051097 03/01/1997       583 Citations
  • p53 status and prognosis of locally advanced prostatic adenocarcinoma: a study based on RTOG 8610. (Grignon DJ, Caplan R, Sarkar FH, Lawton CA, Hammond EH, Pilepich MV, Forman JD, Mesic J, Fu KK, Abrams RA, Pajak TF, Shipley WU, Cox JD) J Natl Cancer Inst 1997 Jan 15;89(2):158-65 PMID: 8998185 SCOPUS ID: 2-s2.0-0031030869 01/15/1997       165 Citations
  • Recombinant human interferon-beta (rHuIFN-beta) and radiation therapy for inoperable non-small cell lung cancer. (Byhardt RW, Vaickus L, Witt PL, Chang AY, McAuliffe T, Wilson JF, Lawton CA, Breitmeyer J, Alger ME, Borden EC) J Interferon Cytokine Res 1996 Nov;16(11):891-902 PMID: 8938564 SCOPUS ID: 2-s2.0-0029827192 11/01/1996       14 Citations
  • Results of a phase II trial of external beam radiation with etanidazole (SR 2508) for the treatment of locally advanced prostate cancer (RTOG Protocol 90-20). (Lawton CA, Coleman CN, Buzydlowski JW, Forman JD, Marcial VA, DelRowe JD, Rotman M) Int J Radiat Oncol Biol Phys 1996 Oct 01;36(3):673-80 PMID: 8948352 SCOPUS ID: 2-s2.0-0030271701 10/01/1996       18 Citations
  • Pulmonary function changes in long-term survivors of bone marrow transplantation. (Gore EM, Lawton CA, Ash RC, Lipchik RJ) Int J Radiat Oncol Biol Phys 1996 Aug 01;36(1):67-75 PMID: 8823260 SCOPUS ID: 2-s2.0-0029814113 08/01/1996       61 Citations
  • Unrelated donor bone marrow transplantation to treat severe aplastic anaemia in children and young adults. (Margolis D, Camitta B, Pietryga D, Keever-Taylor C, Baxter-Lowe LA, Pierce K, Kupst MJ, French J 3rd, Truitt R, Lawton C, Murray K, Garbrecht F, Flomenberg N, Casper J) Br J Haematol 1996 Jul;94(1):65-72 PMID: 8757510 SCOPUS ID: 2-s2.0-8944254249 07/01/1996       89 Citations
  • RTOG's first quality of life study--RTOG 90-20: a phase II trial of external beam radiation with etanidazole for locally advanced prostate cancer. (Watkins-Bruner D, Scott C, Lawton C, DelRowe J, Rotman M, Buswell L, Beard C, Cella D) Int J Radiat Oncol Biol Phys 1995 Nov 01;33(4):901-6 PMID: 7591900 SCOPUS ID: 2-s2.0-0028826389 11/01/1995       68 Citations
  • Therapeutic plasma exchange does not appear to be effective in the management of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome following bone marrow transplantation. (Sarode R, McFarland JG, Flomenberg N, Casper JT, Cohen EP, Drobyski WR, Ash RC, Horowitz MM, Camitta B, Lawton C) Bone Marrow Transplant 1995 Aug;16(2):271-5 PMID: 7581147 SCOPUS ID: 2-s2.0-0029150064 08/01/1995       99 Citations
  • Unrelated bone marrow donor transplants for children with leukemia or myelodysplasia. (Casper J, Camitta B, Truitt R, Baxter-Lowe LA, Bunin N, Lawton C, Murray K, Hunter J, Pietryga D, Garbrecht F) Blood 1995 May 01;85(9):2354-63 PMID: 7727769 SCOPUS ID: 2-s2.0-0028921178 05/01/1995       133 Citations
  • Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group. (Pilepich MV, Krall JM, al-Sarraf M, John MJ, Doggett RL, Sause WT, Lawton CA, Abrams RA, Rotman M, Rubin P) Urology 1995 Apr;45(4):616-23 PMID: 7716842 SCOPUS ID: 2-s2.0-0028880521 04/01/1995       484 Citations
  • Bone marrow transplant nephropathy: radiation nephritis revisited. (Cohen EP, Lawton CA, Moulder JE) Nephron 1995;70(2):217-22 PMID: 7566307 SCOPUS ID: 2-s2.0-0029059253 01/01/1995       91 Citations
  • PSA screening. (Wilson JF, Hussey DH, Lawton CA, Leibel SA, Shipley WU) J Fam Pract 1994 Sep;39(3):216-7 PMID: 7521388 SCOPUS ID: 2-s2.0-0028503050 09/01/1994    
  • Prostate cancer: are racial differences in clinical stage and survival explained by differences in symptoms? (Lawton CA, Cantrell JE, Derus SW, Murray KJ, Byhardt RW, Wilson JF) Radiology 1994 Jul;192(1):37-40 PMID: 8208961 SCOPUS ID: 2-s2.0-0028336895 07/01/1994       10 Citations
  • Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia. (Drobyski WR, Ash RC, Casper JT, McAuliffe T, Horowitz MM, Lawton C, Keever C, Baxter-Lowe LA, Camitta B, Garbrecht F) Blood 1994 Apr 01;83(7):1980-7 PMID: 8142664 SCOPUS ID: 2-s2.0-0028179358 04/01/1994       126 Citations
  • Effect of nephrotoxic drugs on the development of radiation nephropathy after bone marrow transplantation. (Lawton CA, Fish BL, Moulder JE) Int J Radiat Oncol Biol Phys 1994 Mar 01;28(4):883-9 PMID: 8138441 SCOPUS ID: 2-s2.0-0028300386 03/01/1994       32 Citations
  • Clinical course of late-onset bone marrow transplant nephropathy. (Cohen EP, Lawton CA, Moulder JE, Becker CG, Ash RC) Nephron 1993;64(4):626-35 PMID: 8366991 SCOPUS ID: 2-s2.0-0027325972 01/01/1993       78 Citations
  • Is long-term survival possible with external beam irradiation for stage D1 adenocarcinoma of the prostate? (Zincke H) Cancer 1992 Dec 01;70(11):2742-3 PMID: 1423207 SCOPUS ID: 2-s2.0-0026486378 12/01/1992       1 Citation
  • Is long-term survival possible with external beam irradiation for stage D1 adenocarcinoma of the prostate? (Lawton CA, Cox JD, Glisch C, Murray KJ, Byhardt RW, Wilson JF) Cancer 1992 Jun 01;69(11):2761-6 PMID: 1571906 SCOPUS ID: 2-s2.0-0026607614 06/01/1992       35 Citations
  • Allogeneic marrow transplantation using T cell depletion for patients with juvenile chronic myelogenous leukemia without HLA-identical siblings. (Bunin NJ, Casper JT, Lawton C, Murray K, Camitta BM, Greenwood M, Geil J, Ash RC) Bone Marrow Transplant 1992 Feb;9(2):119-22 PMID: 1571710 SCOPUS ID: 2-s2.0-0026560027 02/01/1992       23 Citations
  • Influence of renal shielding on the incidence of late renal dysfunction associated with T-lymphocyte deplete bone marrow transplantation in adult patients. (Lawton CA, Barber-Derus SW, Murray KJ, Cohen EP, Ash RC, Moulder JE) Int J Radiat Oncol Biol Phys 1992;23(3):681-6 PMID: 1612975 SCOPUS ID: 2-s2.0-0026750265 01/01/1992       53 Citations
  • Twice-daily tapering dexamethasone treatment during cranial radiation for newly diagnosed brain metastases. (Weissman DE, Janjan NA, Erickson B, Wilson FJ, Greenberg M, Ritch PS, Anderson T, Hansen RM, Chitambar CR, Lawton CA) J Neurooncol 1991 Dec;11(3):235-9 PMID: 1726656 SCOPUS ID: 2-s2.0-0026332525 12/01/1991       46 Citations
  • Allogeneic bone marrow transplantation for relapsed and refractory lymphoma using genotypically HLA-identical and alternative donors. (Lundberg JH, Hansen RM, Chitambar CR, Lawton CA, Gottlieb M, Anderson T, Ash RC) J Clin Oncol 1991 Oct;9(10):1848-59 PMID: 1919635 SCOPUS ID: 2-s2.0-0025994888 10/01/1991       34 Citations
  • Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706. (Lawton CA, Won M, Pilepich MV, Asbell SO, Shipley WU, Hanks GE, Cox JD, Perez CA, Sause WT, Doggett SR) Int J Radiat Oncol Biol Phys 1991 Sep;21(4):935-9 PMID: 1917622 SCOPUS ID: 2-s2.0-0025946138 09/01/1991       372 Citations
  • Late renal dysfunction in adult survivors of bone marrow transplantation. (Lawton CA, Cohen EP, Barber-Derus SW, Murray KJ, Ash RC, Casper JT, Moulder JE) Cancer 1991 Jun 01;67(11):2795-800 PMID: 2025844 SCOPUS ID: 2-s2.0-0025810093 06/01/1991       92 Citations
  • Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors. (Ash RC, Casper JT, Chitambar CR, Hansen R, Bunin N, Truitt RL, Lawton C, Murray K, Hunter J, Baxter-Lowe LA) N Engl J Med 1990 Feb 22;322(8):485-94 PMID: 2300120 SCOPUS ID: 2-s2.0-11944271130 02/22/1990       263 Citations
  • Bone marrow transplantation for children with severe aplastic anemia: use of donors other than HLA-identical siblings. (Camitta B, Ash R, Menitove J, Murray K, Lawton C, Hunter J, Casper J) Blood 1989 Oct;74(5):1852-7 PMID: 2529004 SCOPUS ID: 2-s2.0-0024430673 10/01/1989       51 Citations
  • Technical modifications in hyperfractionated total body irradiation for T-lymphocyte deplete bone marrow transplant. (Lawton CA, Barber-Derus S, Murray KJ, Casper JT, Ash RC, Gillin MT, Wilson JF) Int J Radiat Oncol Biol Phys 1989 Aug;17(2):319-22 PMID: 2666364 SCOPUS ID: 2-s2.0-0024393731 08/01/1989       45 Citations
  • Extended-field radiation therapy for prostatic carcinoma with para-aortic lymph node metastasis. (Lawton CA, Glisch C, Byhardt RW, Sehring S, Hartz A, Cox JD) Am J Clin Oncol 1986 Aug;9(4):302-6 PMID: 3751968 SCOPUS ID: 2-s2.0-0022919048 08/01/1986       5 Citations
    • Last update: 06/23/2026